Analgesic Effect of Accelerated Repetitive Transcranial Magnetic Stimulation in Neuropathic Pain

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorJakub Antczak

About this trial

Peripheral neuropathy is a frequent condition, commonly associated with pain. Repetitive Transcranial Magnetic Stimulation (rTMS) is a noninvasive method of modulation of brain plasticity and is regarded as one of alternative methods to alleviate pain associated with various kind of neuropathies. rTMS is usually performed once a day and the whole therapy of neuropathic pain lasts one week. In a number of recent clinical trials including patients with depression and some other disorders, rTMS was delivered several times a day, which reduced the time of the whole therapy. This approach was termed an accelerated rTMS. The purpose of this study is to investigate feasibility of accelerated rTMS in treatment of neuropathic pain.

Eligibility criteria

Qualifiers

Diagnosis of peripheral neuropathy

Neuropathic pain of constant severity since not less than a month and requiring use of analgesics more than once a week

Score of 30 millimeter or more on the 100 millimeter visual analog scale of pain intensity at inclusion

Disqualifiers

Severe depression

Personality disorders and other psychiatric conditions, which could disturb the participation in the study

Cognitive deficits, which could disturb the participation in the study

Epilepsy

Trial design

Treatments tested in this trial

  • Active repetitive transcranial magnetic stimulation
  • Sham repetitive transcranial magnetic stimulation

Treatment groups

70 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Jakub Antczak

Lead sponsor

Jagiellonian University

Sponsor institution